All Type of News
Most smaller pharmaceutical companies still sweating over 2012 business plan
A majority of small- and medium-sized Korean drug firms are still struggling to finalize their business plans for the new year, according to pharmaceutical business sources.
The government’s large drug price cut p...
Plan to readjust dispensing charge provokes complaint
The government's plan to reformulate the dispensing charges by 25 sectors has provoked criticism from pharmacists who run community pharmacies.
The Ministry of Health and Welfare said that it will increase the disp...
Vosodilator buflomedil injection to be banned
The Korea Food and Drug Administration (KFDA) said yesterday it has decided to ban sales of buflomedil-containing drugs, mostly used to treat peripheral arterial occlusive disease, following the sales ban of oral bufl...
Generic giants to get easier access to Korean pharmaceutical market
The government plans to slash the price of about half the drugs on the market by an average of 14 percent starting next April.
The price cuts, designed to reduce national health insurance expenditures, left pharmac...
High-income households favor OTC drugs and health products
High-earning earners with a higher educational background tend to buy more over-the-counter (OTC) and quasi-drugs and functional health products, while low-income households with a poor education level want to purchas...
Boryung to boost sales of Kanarb in Central and South America
Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, said recently that it will strengthen a strategic alliance with Stendhal SA, a leading pharmaceutical firm in Mexico in an effort to expand ...
Government to fix drug management fee at 470 won per visit
From next January, pharmacy’s drug management fee will be fixed at 470 won per visit, and dispensing fee for more than two-day prescription will slightly rise, according to the Ministry of Health and Welfare.
Under...
BPH in elderly men rises
Benign prostatic hyperplasia (BPH) among the elderly male population is rising, the Health Insurance Review & Assessment Service revealed Monday.
According to the HIRA, the number of people treated for BPH marked 7...
Health ministry dismisses KORUS FTA rumor on health insurance
The Ministry of Health and Welfare are dumbfounded at bizarre assertion that the U.S.-South Korea Free Trade Agreement (FTA), which was ratified in the National Assembly, will lead to increase of insurance-covered dru...
Restructuring plans in pharmaceutical firms hit snag
Influenced by the government’s large drug price cuts, many pharmaceutical companies are trying to survive through a massive reconstructing plan, but they are facing a strong resistance from sales persons.
A report ...
